| Ticker Symbol: | NBS |
|---|---|
| Exchange: | AMEX |
| Contact Info: | 420 Lexington Avenue New York NY 10170 212-584-4180 |
| CEO/President: | Robin L. Smith |
| Industry: | Medical - Dental Suppliers / Standard Industry Code: 8090 |
| Description: | NeoStem, Inc., is an innovative, publicly traded company positioned to become a leader in the adult stem cell field and to capitalize on the increasing importance adult stem cells are expected to play in the future of regenerative medicine. |
| Shares Outstanding: | 5,120 (000) | Market Value: | 7,570 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 13.46% | Number of Inst.Shareholders: | 11.00% |
| Last Quarter Sales: | 0.02 ($Mil.) | Last Quarter Net Income: | -2.36 ($Mil.) |
| Last Quarter EPS: | -0.43 | P/E Ratio: | 0 |
| Most Recent Earnings: | Earnings Per Share: | -0.94 | |
| Most Recent Split: | Annual Dividend Rate: | 0 | |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |

| COVIDIEN LTD | +26.70 | 52.19 | |
| BECTON DICKINSO | -5.10 | 80.24 | |
| PATTERSON COMPA | -26.60 | 28.87 | |
| LABORATORY CORP | -16.30 | 66.33 | |
| DENTSPLY INTL I | -9.90 | 37.66 |
